P2.04-51 A 6-Gene Immune Genomic Signature (IGS) Predicts Resistance to Nivolumab [NIV] in Advanced Pretreated NSCLC: Results of PRINCiPe Trial
| Autor: | Pilotto, S., Di Noia, V., Sperduti, I., Grizzi, G., D'Argento, E., Simbolo, M., Vicentini, C., Caliò, A., Mafficini, A., Carbognin, L., Corbo, V., Gkountakos, A., Vita, E., Santo, A., Brunelli, M., Martini, M., Scarpa, A., Milella, M., Tortora, G., Bria, E. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; October 2019, Vol. 14 Issue: 10, Number 10 Supplement 1 pS728-S728, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|